FibroTest

From WikiMD.org
Jump to navigation Jump to search

FibroTest

FibroTest (pronounced: /ˈfaɪbroʊˌtɛst/) is a non-invasive medical test used to assess liver fibrosis and cirrhosis. It is also known as the BioPredictive FibroTest.

Etymology

The term "FibroTest" is derived from the words "fibrosis", referring to the medical condition it helps to diagnose, and "test", indicating its function as a diagnostic tool.

Description

FibroTest is a blood test that measures the levels of certain biochemical markers in the blood, including haptoglobin, apolipoprotein A1, bilirubin, gamma glutamyl transpeptidase (GGT), and alanine aminotransferase (ALT). These markers are used to calculate a score that indicates the degree of liver fibrosis or cirrhosis.

The FibroTest is often used in conjunction with other diagnostic tools, such as the FibroScan, to provide a comprehensive assessment of liver health. It is particularly useful in patients who are at risk of developing liver disease, such as those with hepatitis C, hepatitis B, alcoholic liver disease, or non-alcoholic fatty liver disease (NAFLD).

Related Terms

  • Fibrosis: The process of forming fibrous tissue, often as a result of inflammation or injury.
  • Cirrhosis: A late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions.
  • Hepatitis: Inflammation of the liver, usually caused by a viral infection.
  • Bilirubin: A yellow compound that occurs in the normal catabolic pathway that leads to the breakdown of heme in vertebrates.
  • Alanine aminotransferase (ALT): An enzyme found mostly in the liver. When liver cells are damaged, they release ALT into the bloodstream.

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski